| Print
Amphastar Pharmaceuticals (AMPH)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Address
11570 6th Street
Rancho Cucamonga
CA
USA
91730
Telephone
+1 909 980-9484
Forecast key dates
| Name | Key Date |
|---|---|
| Amphastar Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-06T14:00:00 |
| Amphastar Pharmaceuticals Inc Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |
| Amphastar Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2026 | 2026-08-07T14:00:00 |
| Amphastar Pharmaceuticals Inc Second Quarter Earnings Results for 2026 | 2026-08-07T00:00:00 |
| Amphastar Pharmaceuticals Inc Annual General Meeting for 2026 | 2026-06-02T11:30:00 |
| Amphastar Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026 | 2026-05-07T14:00:00 |
| Amphastar Pharmaceuticals Inc First Quarter Earnings Results for 2026 | 2026-05-07T00:00:00 |
| Amphastar Pharmaceuticals Inc Annual Report for 2025 | 2026-03-03T00:00:00 |
| Amphastar Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-27T14:00:00 |
| Amphastar Pharmaceuticals Inc Fourth Quarter Earnings Results for 2025 | 2026-02-27T00:00:00 |
| 37th Annual Piper Sandler Healthcare Conference | 2025-12-03T14:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.